Researchers report that brain scan tracer uptake patterns can help identify which slow-growing diffuse lower-grade gliomas are more likely to trigger seizures. The work focuses on a practical clinical problem where seizure onset can be the first sign of disease and can significantly disrupt quality of life. The study, highlighted in a clinical research update, uses tracer imaging to separate tumor biology associated with seizure propensity from those with lower risk, potentially guiding surveillance intensity and early interventions. If validated prospectively, the approach could refine how clinicians counsel patients and structure follow-up plans for seizure prevention in glioma care pathways.